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Haptoglobin preserves the CD163 hemoglobin scavenger
pathway by shielding hemoglobin from peroxidative
modification
Abstract
Detoxification and clearance of extracellular hemoglobin (Hb) have been attributed to its removal by the
CD163 scavenger receptor pathway. However, even low-level hydrogen peroxide (H(2)O(2)) exposure
irreversibly modifies Hb and severely impairs Hb endocytosis by CD163. We show here that when Hb
is bound to the high-affinity Hb scavenger protein haptoglobin (Hp), the complex protects Hb from
structural modification by preventing alpha-globin cross-links and oxidations of amino acids in critical
regions of the beta-globin chain (eg, Trp15, Cys93, and Cys112). As a result of this structural
stabilization, H(2)O(2)-exposed Hb-Hp binds to CD163 with the same affinity as nonoxidized complex.
Endocytosis and lysosomal translocation of oxidized Hb-Hp by CD163-expressing cells were found to
be as efficient as with nonoxidized complex. Hp complex formation did not alter Hb's ability to
consume added H(2)O(2) by redox cycling, suggesting that within the complex the oxidative radical
burden is shifted to Hp. We provide structural and functional evidence that Hp protects Hb when
oxidatively challenged with H(2)O(2) preserving CD163-mediated Hb clearance under oxidative stress
conditions. In addition, our data provide in vivo evidence that unbound Hb is oxidatively modified
within extravascular compartments consistent with our in vitro findings.
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RED CELLS, IRON, AND ERYTHROPOIESIS
Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding
hemoglobin from peroxidative modification
Paul W. Buehler,1 Bindu Abraham,1 Florence Vallelian,2 Charlotte Linnemayr,2 Claudia P. Pereira,2 John F. Cipollo,1
Yiping Jia,1 Malgorzata Mikolajczyk,1 Felicitas S. Boretti,3 Gabriele Schoedon,2 Abdu I. Alayash,1 and Dominik J. Schaer2
1Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration (FDA), Washington, DC; and 2Division of Internal Medicine,
Inflammation Research and 3Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
Detoxification and clearance of extracellu-
lar hemoglobin (Hb) have been attributed
to its removal by the CD163 scavenger
receptor pathway. However, even low-
level hydrogen peroxide (H2O2) exposure
irreversibly modifies Hb and severely im-
pairs Hb endocytosis by CD163. We show
here that when Hb is bound to the high-
affinity Hb scavenger protein haptoglobin
(Hp), the complex protects Hb from struc-
tural modification by preventing -globin
cross-links and oxidations of amino acids
in critical regions of the -globin chain
(eg, Trp15, Cys93, and Cys112). As a
result of this structural stabilization, H2O2-
exposed Hb-Hp binds to CD163 with the
same affinity as nonoxidized complex.
Endocytosis and lysosomal translocation
of oxidized Hb-Hp by CD163-expressing
cells were found to be as efficient as with
nonoxidized complex. Hp complex forma-
tion did not alter Hb’s ability to consume
added H2O2 by redox cycling, suggesting
that within the complex the oxidative radi-
cal burden is shifted to Hp. We provide
structural and functional evidence that
Hp protects Hb when oxidatively chal-
lenged with H2O2 preserving CD163-
mediated Hb clearance under oxidative
stress conditions. In addition, our data
provide in vivo evidence that unbound
Hb is oxidatively modified within extravas-
cular compartments consistent with
our in vitro findings. (Blood. 2009;113:
2578-2586)
Introduction
When Hb is released into the extracellular space during
hemolysis or tissue injury it can be toxic to the environment.1
Hb cytotoxicity has been attributed to oxidative processes
driven by the heme group. The primary binding protein for
extracellular Hb is haptoglobin (Hp), which binds Hb irre-
versibly with a rate constant of 5.5  105 M1s1.2 Following
complex formation, Hb-Hp is removed by circulating
blood monocytes and tissue macrophages via the Hb
scavenger receptor CD163.3-7 However, we have pre-
viously shown that even in the absence of Hp a lower affinity
interaction between Hb and CD163 allows for efficient endocy-
tosis and degradation of Hb by macrophages.7 The precise role
of Hp in the CD163-mediated Hb clearance pathway remains
therefore elusive.
Exposure of Hb to H2O2 induces structural modifications, which
include altered heme protein product formation, extensive cross-
linking of -globin chains, and irreversible oxidative modifications
of specific amino acids within the CD163 binding region of the Hb
-globin chain.8,9 These structural alterations result in reduced
CD163 binding, and severely impair endocytosis of oxidized Hb by
CD163.10 Therefore, failure of Hb clearance by endogenous
mechanisms could aggravate tissue injury.
The ubiquitous oxidant molecule H2O2 is generated as a result
of superoxide (O2) dismutation and is the major reactive oxygen
species produced during metabolic processes.11 Highly elevated
tissue concentrations of H2O2 occur during inflammation and tissue
injury as a consequence of the oxidative burst activity of granulo-
cytes and macrophages.12 Within diseased tissue, H2O2 concentra-
tions in excess of 100 M have been measured, though 1 to 15 M
appears to be the upper limit of a healthy physiologic range.11 In the
presence of H2O2, extracellular Hb is susceptible to heme iron, and
protein oxidation associated with pseudoperoxidase activity of Hb.
H2O2 oxidizes ferrous Hb (Fe2) to generate the oxo-ferryl
(Fe4  O2) state and, in the case of the reaction with ferric Hb
(Fe3), a protein radical (Hb Fe4  O2) is formed as follows:
(1) Hb (Fe2)  H2O23Hb (Fe4  O2)  H2O; (2) Hb
(Fe2)  Hb (Fe4  O2)  H 3Hb (Fe3)  OH; (3) Hb
(Fe3)  H2O23 Hb Fe4  O2  H2O.
Whereas classic peroxidases stabilize the radical on the porphyrin,
the radical formed during the pseudoperoxidase cycles of Hb
typically migrates away from the heme group, yielding a radical
cation on an amino acid residue.13 Although strong oxidative
conditions are usually required to irreversibly damage nonheme
proteins,14,15 the radical formation during these cycles of H2O2
reaction renders Hb highly susceptible to oxidative modification in
the presence of very low concentrations of H2O2.8,16
Our previous work defined specific amino acids within the
-globin chain as a target of H2O2-induced heme radical formation
and migration. Cys93 and Cys112 underwent irreversible oxida-
tion to cysteic acid, whereas Trp15 was found to oxidize to
oxyindolyl and kynureinyl products. Extensive protein-protein
cross-linking and heme adduct formation characterize the oxidative
modification of -globin subunits.8 Beyond the impaired CD163
binding and clearance of oxidatively altered Hb products, these
modifications may result in the occurrence and accumulation of
potential neoantigens or inflammatory by-products.17
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Hp is supposed to serve as an antioxidant through control of
Hb-mediated oxidative side reactions and subsequent tissue dam-
age.18 However, it has not been established whether Hp could also
specifically stabilize Hb during oxidative insult and whether it
could prevent H2O2-induced structural Hb modifications. Hp is
released in large quantities by activated granulocytes at local sites
of inflammation and tissue injury where also free Hb typically
accumulates as a result of red blood cell lysis.19 Hb complexation
by Hp seems thus to play a particularly important role during
inflammation and tissue injury—conditions intimately associated
with enhanced oxidative stress.20
The present study confirms that the in vitro characterized
oxidative modifications do also occur in Hb exposed to oxidative
stress in vivo. All H2O2-induced modifications are shown to be
prevented when Hb is scavenged by Hp before it is exposed to
H2O2. As a result, CD163 receptor binding, cellular uptake, and
lysosomal sequestration were preserved even after Hb-Hp exposure
to the most severe oxidative conditions tested. Taken together,
these data suggest that induction and/or administration of Hp may
have therapeutic potential in several acute and chronic hemolytic
disease states.
Methods
Hemoglobin and haptoglobin sample preparation
We used highly purified human Hb (HbA0), which was a gift from Hemosol
(Mississauga, ON). The purity of this Hb is 99.99%21 and has been
confirmed by extensive characterizations.22,23 Human Hp 1-1 and 2-2 were
from Sigma-Aldrich (St Louis, MO) and are 99% pure. Hemoglobinuria in
beagle dogs was induced by continuous infusion of stroma-free HbA0 over
8 hours (a gift from Sangart, San Diego, CA) targeted to a constant plasma
concentration of approximately 100 M (heme). The dog Hb infusion
experiments were approved by the animal research commission of the
Kanton of Zurich, Switzerland.
Oxidation of hemoglobin and hemoglobin-haptoglobin
complexes
Hb (250 M, heme) was treated either with 5, 10, and 40 mU/mL glucose
oxidase for 2 and 16 hours generating approximately 1.5 M H2O2/min at
10 mU/mL glucose oxidase as previously reported by our laboratory24 or
with stoichiometric to suprastoichiometric boluses of H2O2 in a 1:1 and
1:10 molar excess of oxidant over heme as previously reported by our
laboratory.8 Steady-state H2O2 concentrations in the GOX system were
measured as 10 to 50 M. Oxidized Hb-Hp (1-1) was prepared as Hb
(250 M, heme) with an equivalent molar protein concentration of Hp to
allow for 1:1 binding followed by oxidation as described previously.8 To
prove complex formation and to exclude effects of nonbound Hb or Hp, we
have analyzed the Hb-Hp complex by high-performance liquid chromatog-
raphy (HPLC) before oxidation (data not shown). Although glucose oxidase
generated H2O2 is thought to be the most physiologically relevant method
for continuous exposure, a clear advantage of bolus additions of H2O2 in our
circumstance is the simplicity of the reaction mixture for the mechanistic
studies described here and that modifications induced by the glucose on the
Hb protein are avoided prior to structural analysis. The same patterns of
amino acid oxidations in Hb were observed with all oxidation procedures,
therefore figures represent the most severe stoichiometric exposures
evaluated (10-fold molar excess H2O2) to emphasize the protective
influence of Hp.
Reverse-phase chromatography
In vitro and in vivo (renal filtrate) samples were separated on a Zobax SB
300 C3 (Agilent Technologies, Wilmington, DE) 250  4.6-mm column
attached to a Water-626 pump and Waters-2487 dual-wavelength detector,
controlled by a Waters-600s controller using Millenium32 software
(Waters, Milford, MA). The mobile phase consisted of (A) 0.1% trifluoro-
acetic acid (TFA) in water and (B) 0.1% TFA in acetonitrile. A gradient was
programmed to deliver 65% (A)/35% (B) over 10 minutes, 63% (A)/37%
(B) after 10 minutes, 60% (A)/40% (B) after 15 minutes, 57% (A)/43%
(B) after 16 minutes, then increased to 90% B over the remaining
40 minutes of the run. Solvents were mixed and run at a rate of 1 mL/min
and absorbencies monitored at 280 nm and 405 nm.25
Mass spectrometric analysis
Samples were reduced and alkylated. Trypsin was added in a 1:25
enzyme-substrate wt/wt ratio. The samples were incubated overnight
( 12 hours) at 37°C. The reaction was quenched by acidifying with
0.1% formic acid. Before introduction into the mass spectrometer (liquid
chromatography/mass spectrometry/mass spectrometry [LC-MS/MS]),
samples were desalted using C18 zip-tips (Millipore, Billerica, MA).
Tryptic peptides (2 L) were mixed in a 10-L solution of alpha-cyano-
4-hydroxycinnamic acid (CHCA) in 50:50 acetonitrile water mixture
containing 0.1% formic acid. After spotting and drying on the target plate,
matrix-assisted laser desorption/ionization (MALDI)–MS analysis was
performed using a 4800 MALDI TOF/TOF mass spectrometer (Applied
Biosystems, Foster City, CA). Data were acquired with Xcalibur
2.0 software (Thermo Scientific, San Jose, CA) and processed using
Bioworks (Thermo Scientific). Peptide searching was performed using
MASCOT26 (detailed description is provided in Document S1, available on
the Blood website; see the Supplemental Materials link at the top of the
online article).
Surface plasmon resonance analyses
Surface plasmon resonance (SPR) was performed using a Biacore 3000
instrument (GE Healthcare, Biacore, Uppsala, Sweden) with purified
CD163 immobilized on CM5 Biacore sensor chips. Detailed protocols of
receptor immobilization and data acquisition are given in Document S1.
Kinetic measurements of peroxidase activity of Hb with or
without haptoglobin
The slower kinetic processes after mixing H2O2 (in molar ratios of 1:1, 1:2,
1:5, and 1:10) with ferrous Hb (50 M heme) with or without Hp (1:1 molar
ratio) were monitored in a thermostated cell of a rapid scanning diode array
spectrophotometer (HP-8453; Agilent Technologies). All experiments were
run at 37°C, in 50 mM phosphate buffer (pH 7.4) that had been previously
treated with Chelex resin (Bio-Rad, Hercules, CA). All spectra were
recorded as a function of time, and representative spectra of ferrous Hb in
the beginning, ferric Hb at the end of the reactions, as well as the
intermediate spectra of ferryl Hb were recorded. Ferric Hb treated with
excess amount of H2O2 was measured in an Applied Photophysics SF-17
stopped-flow spectrophotometer (Surrey, United Kingdom) in 50 mM
phosphate buffer (pH 7.4) at room temperature as previously reported.27
Several spectra were captured as a function of time using an Applied
Photophysics photodiode array accessory. A minimum of 200 spectra were
collected in a given time period with a resolution of 2.38 ms per spectrum
for each reaction. The whole set of spectral data was then subjected to
global analysis and curve fitting (Applied Photophysics software). Spectra
of major reaction species from ferric Hb to ferryl Hb were reconstructed,
and the reaction rate constants were obtained from the analysis. The
experiments were carried out with increasing H2O2 concentrations in the
presence or absence of Hp.
Hb endocytosis and competitive cellular uptake assay
Culture of CD163-transduced HEK293 cells (CD163-HEK293) and the
fluorescent Hb-Hp uptake assay were performed as described.7 To quantify
Hb endocytosis by fluorescence microscopy, cells were incubated with the
indicated ligands, washed, fixed with paraformaldehyde, permeabilized
with Triton X-100, and stained with polyclonal rabbit anti-Hb (1:1000;
Abcam, Cambridge, United Kingdom) and Alexa 568 goat anti–rabbit
(1:1000; Molecular Probes, Eugene, OR) antibodies. We confirmed that the
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anti-Hb antibody reacted equally with nonoxidized and oxidized Hb by
Western blot (data not shown). Samples were examined with a Carl Zeiss
epifluorescence Axioskope-2 equipped with an AxioCam-MR digital cam-
era and Axio-Vision software (Carl Zeiss, Feldbach, Switzerland). For
quantification, red channel fluorescence of at least 10 microphotographs per
coverslip was quantified using SigmaScan software (Systat Software,
Chicago, IL). Values were corrected for the number of DAPI-stained nuclei
to get arbitrary fluorescence per cell values.28 For subcellular localization of
Hb-Hp cells were additionally stained with mouse anti–LAMP-1 and Alexa
488 goat anti–mouse antibodies. Samples were analyzed as 0.2-m-thick
optical sections using a Leica SP2-AOBS-UV confocal laser-scanning
microscopy system (CLSM; Leica, Heidelberg, Germany) with an optical
magnification of 630. Images were processed using Imaris (Bitplane,
Zurich, Switzerland).
Quantification of HO-1 mRNA and protein by quantitative
real-time PCR and Western blot
HO-1 mRNA abundance was quantified and normalized to GAPDH levels with
LightCycler (Roche Diagnostics, Basel, Switzerland) polymerase chain reaction
(PCR) system as described.7 SDS–polyacrylamide gel electrophoresis (PAGE) of
total cellular extracts and Western blot detection of HO-1 were performed using a
polyclonal antibody to HO-1 (Stressgen, Victoria, BC) and goat anti–rabbit
HRP-conjugated secondary reagent (Amersham, Arlington Heights, IL). Blots
were developed with enhanced chemiluminescence (ECL Plus; Amersham) and
analyzed on a Chemi Doc XRS system (Bio-Rad, Hercules, CA). For direct
staining of native and H2O2-reacted Hb in PAGE gels, gels were fixed and stained
with the Silver-Plus kit (Bio-Rad).29
Results
Identification of oxidatively altered Hb in vivo
We recently demonstrated that exposing Hb to a range of H2O2
concentrations in vitro results in a highly reproducible pattern of
amino acid oxidations, heme protein adducts, and globin chain
cross-linking.8,10 We have now considered a pathophysiologic
condition where Hb is potentially exposed to peroxides in vivo.
During severe hemolysis non–Hp-bound Hb is readily filtered by
the kidney and it has previously been shown that hemoproteins
such as myoglobin do redox cycle H2O2 and lipid peroxides in the
kidney.30 We have therefore evaluated a dog model of free Hb
infusion with hemoglobinuria to study the structural changes
imparted to Hb when it escapes the antioxidant plasmatic compart-
ment and enters an acidic pro-oxidant environment. The largely
protein-depleted urine further offers the unique possibility to study
the excreted Hb in a low background environment with the same
technical approaches that we previously used to characterize
oxidative Hb modifications in vitro. Compared with the HPLC
profile of native Hb, the HPLC profile of dog urine collected during
infusion of stroma-free Hb revealed altered globin chains and
altered heme protein products that elute at 22.0 minutes (Figure
1A). Previous work has demonstrated the same oxidation-induced
altered heme protein product in CSF following subarachnoid
hemorrhage.31 We have shown that high-mass MALDI-MS offers a
convenient and specific approach to identify covalently cross-
linked Hb subunits.10 Figure 1B shows representative MALDI-MS
spectra of renally filtered Hb that closely resembles the spectrum
obtained with in vitro–oxidized Hb. A prominent peak of co-
valently cross-linked dimers (30.9 kDa) occurs in addition to
smaller trimer (46.7 kDa) and tetramer (62.6 kDa) peaks. No
high-molecular masses can be found in native Hb. In addition,
whereas only the nonoxidized -globin Cys112 can be detected in
plasma, the same amino acid is almost completely converted to its
triple oxidation product (cysteic acid) upon passage through the
renal compartment (Figure 1C). Of note, within plasma the
nonoxidized cell-free Hb was found mainly to circulate bound
within the Hb-Hp complex, whereas the noncomplexed Hb is
rapidly excreted by the kidney.
Haptoglobin prevents peroxide-induced hemoglobin amino
acid oxidation
Addition of Hp to Hb prior to H2O2 oxidation protects against
-globin chain amino acid modification(s) and limits -globin
chain cross-linking. Figure 2 shows a representative HPLC chro-
matogram of Hb with - and -globin chains eluting at 22.0 and
23.0 minutes, respectively. H2O2 oxidation caused a decrease in
single globin chain absorbance with altered - and -globin chains
eluting at 24 minutes, demonstrating that the addition of Hp 1-1
prior to H2O2 oxidation preserves - and -globin chains. Heme
alone in the oxidized Hb-Hp (oxHb-Hp) chromatogram elutes at
18.0 minutes, whereas oxidized Hb (oxHb) heme and nonoxidized
Hb heme elute at 19.0 minutes and 16.0 minutes, respectively. We
have previously established that heme is internalized within Hb and
involved in globin chain cross-linking following Hb exposure to
H2O2, hence the observed change in heme retention times.8 In an
extensive mass spectrometry evaluation of H2O2-exposed Hb-Hp,
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Figure 1. Identification of oxidatively modified hemoglobin in vivo. Panels A
throuch C demonstrate oxidative modification to Hb following hemoglobinuria (Hb-U).
(A) The reverse-phase HPLC of hemoglobin within dog urine. During the initial elution
time (0-10 minutes) altered heme is shown. At approximately 23 minutes, a
heme-altered protein product elutes, consistent with an identical HPLC analysis of
CSF.31 Neither altered heme nor heme protein adducts are observed in native highly
purified stroma-free hemoglobin from plasma (right panel). (B) -Globin chain
cross-links ([M  H]  30.9 m/z) and stabilized tetramer ([M  H]  62.6 m/z) from
a representative Hb-U sample. This spectra is identical to a representative oxidized
Hb sample (1:10, HbA0/H2O2) (OxHb) and demonstrates a similar  cross-link ion
([M  H]  30.2 m/z) found in XLHb. The high-mass ions are absent in nonmodified
Hb, which demonstrates only single - and -globin chain ions. (C) The full scan
spectra of the reduced and alkylated Cys112 peptide (L105LGNVLVC112
[CH2CONH2]VLAHHFGK120 [M  3H]  593.14, M  1719.95  56  1775.95)
shown to be nonoxidized in circulating plasma Hb. Within urine, the same Hb peptide
is almost exclusively found as a trioxidation product on Cys112 (cysteic acid)
(L105LGNVLVC112[O3]VLAHHFGK120 [M  3H]  590.2, M  1719.95  48
[3 oxygens],  1767.95).
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we did not find any Hb modifications indicating heme cross-links
or globin chain–bound heme groups. The absence of these findings
in oxidized Hb-Hp may therefore suggest heme transfer and
binding to Hp instead of Hb during oxidation of the complex. The
additional peaks in the oxidized Hb-Hp chromatogram likely
originate from oxidative modifications within the Hp protein.
Verification of amino acid oxidations
The protective influence of Hp on H2O2-mediated Hb amino acid
oxidation is summarized in Table 1. Cys93 oxidation to the
trioxidation product cysteic acid and the protective role of Hp are
demonstrated in the MALDI-TOF mass spectra shown in Figure 3
as a representative example for other amino acids. In the absence of
previous modification to cysteine residues, reduction and alkyla-
tion of sulfhydryl groups prior to trypsin digestion add 56.0 mass
units to cysteine as (CH2CONH2). This is observed in Figure 3A
through D where monoisotopic masses (m/z 2585.2 [M H]) of
the alkylated peptide G83TFATLSELC93 (CH2CONH2) DKLHVD-
PENFR104 are observed at m/z 2529.2 (M  H). In the event of
cysteine oxidation, the equivalent mass of one or more oxygen
atoms is bound to the cysteine as seen in panel B where a mass
equivalent to 3 oxygen atoms was observed on Cys93. These data
clearly demonstrate the protective influence of Hp on the irrevers-
ible oxidation of one of several amino acids within the Hb -globin
chain. Amino acid sequences for all oxidized peptides were verified
by LCMS/MS analysis (Figure S1).
To gain further insight into the potential mechanism by which
Hb amino acids (Trp15, Cys93, Cys112, His117, Tyr145,
and His146) could be protected within the Hb-Hp complex,
distances were calculated for each of these residues to proposed Hp
binding/contact sites32-38 (Figure S1). Trp15, His117, Tyr145,
and His146 are located within 1 of the 3 binding regions, whereas
Cys93 and Cys112 display close proximity to one or more of the
proposed binding sites (Figure S1). The proximity to Hb-Hp
contact sites might suggest reduced surface accessibility of suscep-
tible amino acids within the Hb-Hp complex and thus could
provide a shielding effect from oxidative attack during H2O2
treatment. Alternatively, proximity to free radical stabilizing amino
acids, such as Tyr or Trp, within Hp may provide oxidative
protection.39-43
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Figure 2. Representative reverse-phase HPLC chromatograms of oxidized (ox)
and nonoxidized Hb-Hp products. Gray lines indicate spectra at 280 nm (protein)
and black lines indicate spectra at 405 nm (heme). The chromatogram of nonoxidized
Hb demonstrates a typical elution pattern of - and -globin chains at 22.0 and
23.0 minutes, respectively. H2O2 causes decreased absorbance of chains at 280 and
coelution with heme at approximately 24.0 minutes. Hp(1-1) elutes at approximately
6.2 minutes (shown as dashed gray and dashed black lines). When complexed with
Hb and exposed to H2O2, several newly formed Hp-related oxidation products elute
between 7 and 8 minutes and at 22.5 minutes. In oxidized Hb-Hp (oxHb-Hp), the Hb 
and  chains retain their elution times similar to nonoxidized Hb at 280 nm, indicating
intact undamaged protein. Red indicates Hb’s - and -globin chains, tan indicates
heme, and blue indicates Hp.
Table 1. Hemoglobin amino acid oxidations following hydrogen peroxide incubations
Beta globin peptides* Hb oxHb Hb-Hp oxHb-Hp
GTFATLSELHC93(-CH2CONH2)†DKLHVDPENFR    
GTFATLSELHC93(-O3H)DKLHVDPENFR    
LLGNVLVC112(-CH2CONH2)*VLAHHFGK    
LLGNVLVC112(-O3H)VLAHHFGK    
FFESFGDLSTPDAVM55(O)GNPK    
SAVTALW15(NFK)GK    
LLGNVLVCVLAHH117(O)FGK    
VVAGVANALAHKY145(OH)H146(O)    
*Listed peptides showing candidate amino acids that have been identified to undergo oxidation () or the lack of it () in the presence of Hp. These amino acids are C93
(Cys93), M55 (Met55), W15 (Trp15), H117 (His117), and Y145 (Tyr145).The mechanism of amino acid oxidation under our experimental conditions has previously been
described.14
†Represent 2-iodoacetamide alkylated sulfhydryl groups in nonoxidized Hb cysteine–containing peptides.
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Figure 3. Representative mass spectra of Hb -globin peptides that contain
cysteine (Cys93) in the presence and absence of Hp. (A) Nonoxidized Hb
peptide (G83TFATLSELC93 [CH2CONH2] DKLHVDPENFR104), showing the 56.0
mass unit alkylated Cys93 consistent with the absence of oxidation (m/z  2585.2
[M  H]). (B) Oxidized Hb showing a mass addition of 47 to Cys93 (G83TFATLSELC93
[O3] DKLHVDPENFR104) consistent with the trioxidation product, cysteic acid
(m/z  2576.2 [M  H]). Both panels C and D demonstrate the absence of significant
oxidation on the Cys93 tryptic peptide before or after oxidation, consistent with
spectra (A). LC/MS/MS amino acid sequence data for all oxidized peptides are
included in Figure S1.
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Haptoglobin prevents peroxide-induced hemoglobin
cross-linking and polymerization
We confirmed our previous observation that H2O2 treatment of
Hb resulted in the formation of oligomeric and polymeric
species that are detectable by reducing SDS-PAGE (Figure 4A).
An -globin–specific Western blot (Figure 4B) suggests that the
dimer/polymer formation is largely attributable to -globin
cross-linking. Hp markedly reduced formation of these large
molecular size Hb species. There was no visible alteration of
free -globin subunits upon treatment of Hb-Hp complexes with
H2O2. MALDI-MS (Figure 4D) analysis confirmed that free
-globin chain mass ions at m/z  15 255.86 (M  H) disap-
pear in oxidized Hb but not in oxidized Hb-Hp complex.
Together, these data suggest that Hp complex formation pre-
vents the extensive  chain modifications that occur when Hb
alone is exposed to H2O2. From our previous work, we knew that
Hb that is chemically cross-linked between the -globin chains
cannot bind to Hp although its peroxidative activity remains
unchanged compared with native Hb.44 Oxidative modification
of XLHb was thus considered an ideal control to dissect
nonspecific effects of Hp (ie, as a H2O2) from the protective
effects specifically mediated through the high-affinity interac-
tion between the 2 proteins. In contrast to the protection of
native Hb, Hp prevented neither cross-linking (Figure 4C) nor
oxidative modification of specific amino acids (data not shown)
within XLHb when exposed to H2O2.
Autoxidative and peroxidative activities of hemoglobin and
hemoglobin-haptoglobin complex
The peroxidative processes associated with heme ultimately
drive free radical formation, radical protein migration, and
amino acid oxidation. Hb spontaneously oxidizes to ferric
and ferryl species in the absence of antioxidative enzymes,
such as superoxide dismutase and catalase.45 The rate of
autoxidation in the absence of Hp (kauto  4.165  102 h1)
was very close to the rate calculated in the presence of Hp
(kauto  3.498  102 h1). The lack of effect of Hp on the
so-called “pseudoperoxidase activity” of Hb was also demon-
strated (Figure 5). When ferrous Hb is treated with equimolar or
higher concentrations of H2O2, a decrease in the absorption
peaks at 540 and 577 nm is accompanied by spectral shifts
indicative of the presence of a ferryl species (peaks at 545 and
580 and a flattened region between 600-700 nm), which occurs
2 to 3 minutes after the initiation of the oxidation reaction. As
the reaction progresses, a significant portion of the ferryl iron
becomes reduced back to the ferric form, with characteristic
peaks at 550, 554, and 630 nm according to the model that we
have previously described46 and summarized in equations 1 to
3 (“Introduction”). The formation and the presence of the ferryl
Hb were further evaluated by dervatization of this species to
sulfHb with sodium sulfide (not shown). In the presence of Hp
(Hb-Hp ratio 1:1), no changes were observed in the pseudoper-
oxidase activity of Hb (Figure 5A,B). To investigate the effects
of Hp on the true “peroxidase” activity of Hb, the conversion of
ferric to ferryl Hb was measured. We followed the transient
kinetics of ferric Hb within a rapid mixing stopped-flow
spectrophotometer in the presence and absence of Hp. Forma-
tion of ferryl Hb following rapid mixing of the ferric Hb with
H2O2 was monitored in the stopped flow using a diode array
detector (Figure 5C). Spectral changes in the Soret and visible
regions were recorded as a function of time as shown in Figure
5D. Two major spectral intermediates of Hb (ferric and ferryl)
were deconvoluted and reconstructed (Figure 5E). The observed
rates of the reaction are linearly dependent on H2O2 concentra-
tion under our pseudo first-order reaction conditions with excess
peroxide (Figure 5F). The second-order rate constants from the
slopes of the plots are shown for both sets of experiments in the
presence and absence of Hp and demonstrate reaction rates of
42 M1s1 and 43.6 M1s1, respectively.
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Figure 4. Distribution of molecular size Hb cross-links and polymers after H2O2
treatment. (A) Silver-stained SDS-PAGE analysis of nonoxidized and H2O2-treated
Hb/Hb-Hp (5 g Hb per lane). Hb was mixed with different concentrations of Hp
(phenotype 1-1) to get Hp/Hb ratios between 2:1 and 0.25:1. The concentration of Hb
was equal in all samples (250 M in heme). Oxidation was performed with a 10-fold
excess concentration of H2O2 over heme where indicated (H2O2) for 60 minutes.
(B) Western blot analysis of nonoxidized and H2O2-treated Hb and Hb-Hp with an
anti–-globin–specific monoclonal antibody (-globin) and with a polyclonal anti-Hp
antibody (Hp). Nonoxidized  DBBF cross-linked Hb was used as a control to prove
-globin specificity of the anti-Hb antibody. With  cross-linked Hb there appears a
strong signal at approximately 30 kDa that represents  dimers, but no signal can be
observed at 15 kDa where fully dissociated -globin chains (monomer) appear in
HbA0. (C) In contrast to HbA0, - cross-linked Hb that does not bind to Hp is not
protected from polymerization when exposed to H2O2 (left panel: [1] marker,
[2] HbA0  H2O2, [3] HbA0-Hp  H2O2; right panel: [1] - Hb  H2O2 [2/3] -
Hb-Hp  H2O2 [2 independent reactions]). (D) MALDI-MS analysis of H2O2-treated
Hb and Hb-Hp. As observed in the -globin Western blot, -chains at m/z
approximately 15 290 disappear during H2O2 treatment of Hb but do not disappear if
Hb is oxidized in the presence of equimolar concentrations of Hp.
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Haptoglobin preserves hemoglobin clearance by the CD163
scavenger pathway following peroxide oxidation
We next investigated whether the structural stabilization by Hp
may also preserve the interaction between the Hb-Hp complex and
CD163. Figure 6A confirms our previous observation that Hb
endocytosis by CD163 is abrogated by treatment of Hb with H2O2.
In contrast, Hb-Hp is avidly taken up by CD163-HEK cells even
after exposure to a 10-fold excess of H2O2. Neither native nor
oxidized Hb-Hp was taken up by CD163 cells. Unaltered binding
of both oxidized and nonoxidized Hb-Hp complexes to CD163 was
confirmed by Biacore SPR analysis as well as with our competitive
Hb-Hp uptake assay in CD163-HEK cells (Figure 6B,C).
Hydrogen peroxide exposure of hemoglobin-haptoglobin
results in reduced heme oxygenase induction
Induction of the heme breakdown enzyme heme oxygenase-1
(HO-1) is the major response of CD163-expressing cells to Hb
exposure47,48 and is an important mechanism against Hb-associated
oxidative stress. Therefore, we evaluated whether oxidative dam-
age to Hb and Hb-Hp affected the HO-1 response. Both nonoxi-
dized Hb and Hb-Hp induced strong expression of HO-1 mRNA
and protein, respectively, in CD163-HEK but not in CD163
HEK293 cells (Figure 7A,B). However, H2O2 treatment of Hb in
the absence and presence of Hp almost completely abrogated the
CD163-dependent HO-1 induction. To confirm that the reduced
HO-1 induction was not a result of altered cellular uptake or
subcellular trafficking of the oxidized complex, we confirmed that
oxidized Hb-Hp complexes were colocalized with LAMP-1–
positive lysosomes 30 minutes after endocytosis (Figure 7C), as
recently reported for nonoxidized Hb-Hp.29 To exclude that the lack
of HO-1 induction by oxidized Hb-Hp was a result of altered/
delayed Hb breakdown, we performed similar experiments with
exposure times of 8, 16, and 24 hours. At each of these time points,
we found only low HO-1 induction by the oxidized complex
compared with the induction by nonoxidized Hb-Hp. During
oxidation by H2O2, heme might be released from Hb and might
induce HO-1 by a nonspecific, CD163-independent mechanism. To
avoid this potentially confounding effect, we have removed the
traces of free heme after H2O2 reaction by filtration. However, the
equally sized heme peaks found in the HPLC profiles of nonoxi-
dized as well as of oxidized and filtered Hb and Hb-Hp, respec-
tively, suggest that only a very minor fraction of heme is actually
released during oxidation and removed in the subsequent purifica-
tion (Figure 2). Increased intracellular heme concentration result-
ing from cellular Hb/Hb-Hp degradation is the main stimulus for
HO-1 induction upon Hb endocytosis and was shown to act
independent of potential CD163 receptor signaling.48 Since no free
heme-associated oxidations were observed by mass spectrometry,
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Figure 5. Spectral changes during the oxidation of Hb by
H2O2. Spectral changes during the oxidation of Hb by H2O2.
(A,B) Hb (50 M in heme) was incubated with 250 M H2O2 at
37°C in 50 mM phosphate buffer, pH 7.4. Spectra were collected
in a fast scanning diode-array spectrophotometer. The represen-
tative spectra of oxy Hb in the beginning, intermediate ferryl Hb,
and ferric Hb at the end of the reaction were shown. (A) Hb
without Hp and (B) Hb preincubated with 50 M Hp. (C-F) The
rate of reaction of ferric Hb with H2O2 to form ferryl Hb. The
reaction rate was evaluated using a stopped-flow equipped with a
photodiode array detector (Applied Photophysics). Spectral
changes in the Soret and visible regions were recorded as a
function of time and H2O2 concentration. (C) Representative
spectral changes recorded after mixing Hb (4 M) with excess
H2O2. (D) Reconstructed spectra of the main reaction species
after the global fitting computation of the data set. (E) Concentra-
tion changes of the main reaction species over time obtained by
the global analysis. The reactions by ferric Hb only or by ferric
Hb preincubated with slight molar excess of haptoglobin
were carried out as a dependent of [H2O2], and plotted in panel F.
(F) Second-order rate constants obtained under our experimental
conditions for met HbA0 (F) and met HbA0 with haptoglobin (E).
The derived rate constants are 42 M1s1 and 43.6 M1s1,
respectively.
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we suspect that covalent heme protein association with Hp (as
suggested in Figure 1) may impair cellular heme sensing. This is
supported by previous work that demonstrated that heme
transfer from ferric Hb to LDL and its subsequent oxidation
were inhibited by approximately 80% in the presence of Hp 1-1
compared with ferric Hb alone, suggesting a high affinity of Hp
1-1 for oxidized heme.49
Discussion
Hb is vulnerable to oxidation and subsequent structural damage as
a result of the reaction of oxidants with its reactive heme groups.
We have recently identified patterns of irreversible oxidation of -
chain amino acids that occur in the presence of H2O2.8 In addition,
H2O2 reaction induces the formation of heme adducted protein as
well as extensive cross-linking and polymerization of Hb -globin
subunits. Accumulation of these potentially immunogenic and
inflammatory Hb oxidation products is a potential mechanism of
exaggerated tissue damage during oxidative stress.10
Evidence of oxidation-induced structural Hb damage has been
found in different in vivo conditions.50 However, the structural
characterization of these modifications remained poorly defined
compared with the in depth structural characterization of the Hb
modifications occurring during in vitro H2O2 exposure.8,51,52 We
have therefore extended our mechanistic in vitro studies by
providing evidence that similar structural oxidative modifications
can be observed during specific pathological conditions. We have
previously demonstrated that exposure to a non–Hp-binding chemi-
cally modified Hb with a long circulating half-life results in
significant heme iron as well as globin chain oxidative processes
within the circulation of guinea pigs.50,53 Based on the short
circulating half life of native extracellular Hb (	 30 minutes) and a
relatively high short-term antioxidant capacity of the circulation, it
is likely that acute exposure to free Hb results in its oxidation
following distribution to extravascular tissue sites and not directly
within the circulation. Hemoglobinuria and myoglobinuria have
been causally linked to kidney damage following severe hemolysis
and rhabdomyolysis.30 The rationale for us to study Hb oxidation
products in hemoglobinuria is based on the fact that it has been
confirmed that heme proteins do redox cycle peroxides within the
kidney (ie, in myoglobinuric animals).30 It was therefore realistic to
expect that specific Hb protein modifications related to its redox
cycling activity could be observed in an experimental model of
hemolysis/hemoglobinuria. Furthermore, the usually very low
protein concentration in urine offers unique conditions for sensitive
and specific analysis of modified Hb in a low background
environment using the same analytic approach as for our in vitro
model. Oxidative modifications to Hb isolated from urine were
consistent with our in vitro findings. These oxidative modifications
included the identification of altered heme protein products,
oxidative induction of cross-linked globin chains, and specific
Figure 6. CD163 interaction and endocytosis of peroxide-treated and untreated
Hb and Hb-Hp. (A) CD163-HEK cells were incubated with 20 g/mL native or
H2O2-treated Hb or Hb-Hp. After 30 minutes, cells were washed, fixed, and stained
with an anti-Hb antibody (red fluorescence, Alexa 568). Nuclei were stained with
DAPI (blue). Images were taken with a Carl Zeiss epifluorescence Axioskope-2
(20/0.43 objective) equipped with an AxioCam-MR digital camera and Axio-Vision
software. Results of digital image analysis and quantification of red fluorescence (per
cell) that indicates cellular Hb uptake are shown in the graph. Bars represent mean
plus or minus SD of 3 independent experiments performed in triplicates with at least
10 images quantified per coverslip. (B) Equal binding of nonoxidized Hb-Hp (top) and
oxidized Hb-Hp (bottom) complexes was confirmed by Biacore analysis over a range
of concentrations (from 2.5-200 nM) normalized to Hb. (C) CD163-HEK cells were
incubated with 3 g/mL fluorescent Hb-Hp633 in the presence or absence of different
concentrations of nonfluorescent competitors (F  Hb-Hp [1-1];E  oxidized Hb-Hp
[1-1]). After 30 minutes, cells were washed, trypsinized, and fluorescence was
determined by fluorescence-activated cell sorting (FACS). Mean channel fluores-
cence values are given as percentage of the Hb-Hp633 fluorescence in the absence of
any competitor. (Mean 
 SD from 3 independent experiments.)
Figure 7. HO-1 expression following cell exposure to peroxide-treated and
untreated Hb-Hp. (A) LightCycler quantification of HO-1 mRNA expression induced
by oxidized and nonoxidized Hb and Hb-Hp in CD163-HEK cells after 8-hour
incubation. Data were normalized for GAPDH expression and represent mean plus or
minus SD from 3 independent experiments (F  nonoxidized; E  H2O2 treated).
(B) HO-1 Western blot of CD163-HEK cell lysates after 12-hour incubation with
oxidized (ox) or nonoxidized Hb/Hb-Hp. (c  nontreated cells.) (C) Subcellular
localization of Hb 30 minutes after endocytosis of oxidized Hb-Hp (1-1) in CD163-
HEK cells. Cells were stained with anti-Hb  Alexa 594 secondary antibody (red) and
anti–LAMP-1  Alexa 488 secondary antibody (green); nuclei were stained with
DAPI (blue). The insert in the merged image demonstrates extensive colocalization of
Hb with LAMP-1–positive lysosomes (colocalization appears yellow). Images were
acquired with a Leica SP2-AOBS-UV confocal laser-scanning microscopy system
(objective 40/1.25, oil).
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amino acid oxidations (eg, trioxidation of -globin Cys112 to
cysteic acid).
Endogenous mechanisms of Hb scavenging are critical to
oxidative protection and detoxification of free Hb. This concept
gained biologic relevance when Hp knockout mice were shown to
be more vulnerable than wild-type mice to oxidative kidney and
lung injury.18,54,55 In addition to CD163, alternative pathways such
as the proposed liver parenchymal cell Hb/Hb-Hp receptor might
participate in systemic Hb clearance, whereas specific scavengers
such as hemopexin bind and detoxify free heme.51,52 The pivotal
importance of the CD163 scavenger receptor pathway became
evident in patients treated with the monocyte/macrophage-
depleting immunotoxin gemtuzumab ozogamicin. In the case of
severe intravascular hemolysis, some of these patients experienced
severe systemic toxicity as a result of delayed Hb clearance.56 The
macrophage scavenger pathway might be even more relevant at
sites of local Hb accumulation following hemorrhage, tissue
damage, or inflammation and it thus seems plausible that this
pathway must be protected from functional failure even in the most
severe oxidative conditions encountered during inflammation and
tissue injury.48
During the course of this investigation, the following observations
were made: (1) Hp prevents H2O2-induced amino acid oxidation in the
chain of bound Hb and prevents -globin cross-linking/polymerization.
(2) Hb retains its ability to consume H2O2 when complexed with Hp but
appears to redirect the radical chemistry initiated at the heme iron
toward Hp. (3) CD163-mediated cellular uptake, and lysosomal seques-
tration of the complex exposed to as high as a 10-fold excess of H2O2,
was nearly identical to the uptake of non–H2O2-exposed Hb-Hp,
indicating that Hb can withstand extreme oxidative insult when shielded
within the complex and still be removed effectively from the extracellu-
lar environment. Thereby, the intimate proximity of vulnerable amino
acids to putative Hb-Hp binding sites may suggest that either Hp
physically blocks the primary oxidizable amino acids in Hb, or it may
interfere with protein electron pathways that allow for free radical
transfer from heme to the protein. We also carried out several experi-
ments to verify the accessibility of the heme in Hb when complexed
with Hp by monitoring its reaction with ligands. We found that oxygen
binding kinetics were only slightly altered and NO binding kinetics were
unchanged, in agreement with earlier reports.57,58
Endocytosis of unprotected Hb after reaction with H2O2 is
severely compromised as a result of impaired interaction of the
damaged Hb with Hp and CD163.10 However, whereas Hp cannot
restore the CD163 binding of already damaged Hb, we found that
reaction of H2O2 with the Hb-Hp complex did not reduce the
high-affinity binding to CD163. Beyond the structural protection of
Hb, Hp seems to have a crucial role in preserving cellular uptake
and lysosomal sequestration of extracellular Hb within oxidative
environments. This novel function of Hp might explain why
neutrophil granulocytes store large quantities of preformed Hp
within their granules that can be released to immediately protect Hb
after leukocyte extravasation into damaged tissues.19 Although we
were able to confirm delivery of oxidized Hb-Hp to lysosomes, the
HO-1 induction by oxidized Hb-Hp was only weak, compared with
the expression observed after incubation of CD163 cells with
nonoxidized Hb-Hp. Since increased intracellular heme concentra-
tion is the principal signal for enhanced HO-1 expression, this
observation is likely explained by impaired heme sensing after
oxidized Hb-Hp uptake. Impaired heme sensing may be a result of
the high affinity of oxidized heme toward Hp and potential
nonspecific heme protein product formation.49
In conclusion, we report here that Hp complex formation
protects Hb against structural damage when exposed to H2O2.
Perhaps most intriguing is that Hp preserves the CD163 Hb
clearance pathway and thus allows lysosomal sequestration of
extracellular Hb under strong oxidative conditions. Although it
remains unclear how the oxidized complex is metabolized once in
the lysosome, the oxidative protection of cell-free Hb by Hp affords
a specific and unique role for Hp in the CD163 Hb scavenger
receptor pathway under oxidative stress conditions. The antioxi-
dant protection afforded by Hp-bound Hb suggests that early
administration of Hp in acute hemolysis or induction of endoge-
nous Hp production in chronic hemolytic diseases may be a
therapeutic modality in the prevention of vascular and extravascu-
lar toxicity induced by cell-free Hb exposures.
Acknowledgments
The findings and conclusions in this article have not been formally
disseminated by the Food and Drug Administration and should not
be construed to represent any agency determination or policy.
This study was supported by the Swiss National Science
Foundation (Bern, Switzerland, grant 31-120658) and the Helmut
Horten Foundation (Lugano, Switzerland; both to D.J.S.).
Authorship
Contribution: P.W.B. and D.J.S. performed experiments, analyzed
data, and wrote the paper; B.A., C.P.P., F.V., C.L., J.F.C., Y.J.,
F.S.B., and M.M. performed experiments; and G.S. and A.I.A.
analyzed data and wrote the paper.
Conflict-of-interest disclosure: The authors declare no compet-
ing financial interests.
Correspondence: Dominik J. Schaer, Medical Clinic Research
Unit, University Hospital, CH-8091 Zurich, Switzerland; e-mail:
dominik.schaer@usz.ch; or Abdu I. Alayash, CBER, FDA, NIH
Building 29, Room 112, 8800 Rockville Pike, Bethesda, MD
20892; e-mail: abdu.alayash@fda.hhs.gov.
References
1. Alayash AI. Oxygen therapeutics: can we tame
haemoglobin? Nat Rev Drug Discov. 2004;3:152-
159.
2. Nielsen MJ, Petersen SV, Jacobsen C, et al. A
unique loop extension in the serine protease do-
main of haptoglobin is essential for CD163 recog-
nition of the haptoglobin-hemoglobin complex.
J Biol Chem. 2007;282:1072-1079.
3. Ba¨chli EB, Schaer DJ, Walter RB, Fehr J,
Schoedon G. Functional expression of the CD163
scavenger receptor on acute myeloid leukemia
cells of monocytic lineage. J Leukoc Biol. 2006;
79:312-318.
4. Kristiansen M, Graversen JH, Jacobsen C, et al.
Identification of the haemoglobin scavenger re-
ceptor. Nature. 2001;409:198-201.
5. Schaer CA, Vallelian F, Imhof A, Schoedon G,
Schaer DJ. CD163-expressing monocytes consti-
tute an endotoxin-sensitive Hb clearance com-
partment within the vascular system. J Leukoc
Biol. 2007;82:106-110.
6. Schaer DJ, Alayash AI, Buehler PW. Gating the
radical hemoglobin to macrophages: the anti-in-
flammatory role of CD163, a scavenger receptor.
Antioxid Redox Signal. 2007;9:991-999.
7. Schaer DJ, Schaer CA, Buehler PW, et al. CD163
is the macrophage scavenger receptor for native
and chemically modified hemoglobins in the ab-
sence of haptoglobin. Blood. 2006;107:373-380.
8. Jia Y, Buehler PW, Boykins RA, Venable RM,
Alayash AI. Structural basis of peroxide-mediated
changes in human hemoglobin: a novel oxidative
pathway. J Biol Chem. 2007;282:4894-4907.
9. Osawa Y, Darbyshire JF, Meyer CA, Alayash AI.
Differential susceptibilities of the prosthetic heme
of hemoglobin-based red cell substitutes. Implica-
tions in the design of safer agents. Biochem
Pharmacol. 1993;46:2299-2305.
HAPTOGLOBIN PREVENTS OXIDATIVE Hb MODIFICATION 2585BLOOD, 12 MARCH 2009  VOLUME 113, NUMBER 11
 For personal use only. at UNIVERSITAETSSPITAL on August 20, 2009. www.bloodjournal.orgFrom 
10. Vallelian F, Pimenova T, Pereira CP, et al. The
reaction of hydrogen peroxide with hemoglobin
induces extensive alpha-globin crosslinking and
impairs the interaction of hemoglobin with endog-
enous scavenger pathways. Free Radic Biol Med.
2008;45:1150-1158.
11. Schro¨der E, Eaton P. Hydrogen peroxide as an
endogenous mediator and exogenous tool in car-
diovascular research: issues and considerations.
Curr Opin Pharmacol. 2008;8:153-159.
12. Martin WJ II. Neutrophils kill pulmonary endothe-
lial cells by a hydrogen-peroxide-dependent path-
way. An in vitro model of neutrophil-mediated lung
injury. Am Rev Respir Dis. 1984;130:209-213.
13. Wilson MT, Reeder BJ. Oxygen-binding haem
proteins. Exp Physiol. 2008;93:128-132.
14. Griffiths SW, King J, Cooney CL. The reactivity
and oxidation pathway of cysteine 232 in recom-
binant human alpha 1-antitrypsin. J Biol Chem.
2002;277:25486-25492.
15. Khor HK, Fisher MT, Schoneich C. Potential role
of methionine sulfoxide in the inactivation of the
chaperone GroEL by hypochlorous acid (HOCl)
and peroxynitrite (ONOO-). J Biol Chem. 2004;
279:19486-19493.
16. Steffek RP, Thomas MJ. Hydrogen peroxide
modification of human oxyhemoglobin. Free
Radic Res Commun. 1991;12-13(pt 2):489-497.
17. Shacter E. Quantification and significance of pro-
tein oxidation in biological samples. Drug Metab
Rev. 2000;32:307-326.
18. Lim SK, Kim H, Lim SK, et al. Increased suscepti-
bility in Hp knockout mice during acute hemoly-
sis. Blood. 1998;92:1870-1877.
19. Theilgaard-Mo¨nch K, Jacobsen LC, Nielsen MJ,
et al. Haptoglobin is synthesized during granulo-
cyte differentiation, stored in specific granules,
and released by neutrophils in response to acti-
vation. Blood. 2006;108:353-361.
20. Scha¨fer M, Werner S. Oxidative stress in normal
and impaired wound repair. Pharmacol Res.
2008;58:165-171.
21. Adamson JG, Moore J. Hemolink, an o-raffinose
crosslinked hemoglobin-based oxygen carrier. In:
Chang TMS, ed. Blood Substitutes: Principles,
Methods, Products and Clinical Trials. Vol 2.
Basel, Switzerland: Karger; 1998:62-81.
22. Boykins RA, Buehler PW, Jia Y, Venable R,
Alayash AI. O-raffinose crosslinked hemoglobin
lacks site-specific chemistry in the central cavity:
structural and functional consequences of
beta93Cys modification. Proteins. 2005;59:840-
855.
23. Nagababu E, Ramasamy S, Rifkind JM, Jia Y,
Alayash AI. Site-specific cross-linking of human
and bovine hemoglobins differentially alters oxy-
gen binding and redox side reactions producing
rhombic heme and heme degradation. Biochem-
istry. 2002;41:7407-7415.
24. D’Agnillo F, Alayash AI. Redox cycling of diaspirin
cross-linked hemoglobin induces G2/M arrest
and apoptosis in cultured endothelial cells. Blood.
2001;98:3315-3323.
25. Vollaard NB, Reeder BJ, Shearman JP, Menu P,
Wilson MT, Cooper CE. A new sensitive assay
reveals that hemoglobin is oxidatively modified in
vivo. Free Radic Biol Med. 2005;39:1216-1228.
26. Matrix Science. Mascot Database. http://www.
matrixscience.com/search_form_select.html. Ac-
cessed July 2008.
27. Alayash AI, Summers AG, Wood F, Jia Y. Effects
of glutaraldehyde polymerization on oxygen
transport and redox properties of bovine hemo-
globin. Arch Biochem Biophys. 2001;391:225-
234.
28. Schaer DJ, Schleiffenbaum B, Kurrer M, et al.
Soluble hemoglobin-haptoglobin scavenger re-
ceptor CD163 as a lineage-specific marker in the
reactive hemophagocytic syndrome. Eur J
Haematol. 2005;74:6-10.
29. Schaer CA, Vallelian F, Imhof A, Schoedon G,
Schaer DJ. Heme carrier protein (HCP-1) spa-
tially interacts with the CD163 hemoglobin uptake
pathway and is a target of inflammatory macro-
phage activation. J Leukoc Biol. 2008;83:325-
333.
30. Moore KP, Holt SG, Patel RP, et al. A causative
role for redox cycling of myoglobin and its inhibi-
tion by alkalinization in the pathogenesis and
treatment of rhabdomyolysis-induced renal fail-
ure. J Biol Chem. 1998;273:31731-31737.
31. Reeder BJ, Sharpe MA, Kay AD, Kerr M, Moore
K, Wilson MT. Toxicity of myoglobin and haemo-
globin: oxidative stress in patients with rhabdo-
myolysis and subarachnoid haemorrhage. Bio-
chem Soc Trans. 2002;30:745-748.
32. Hwang PK, Greer J. Identification of residues in-
volved in the binding of hemoglobin alpha chains
to haptoglobin. J Biol Chem. 1979;254:2265-
2270.
33. Hwang PK, Greer J. Interaction between hemo-
globin subunits in the hemoglobin haptoglobin
complex. J Biol Chem. 1980;255:3038-3041.
34. Kazim AL, Atassi MZ. Haemoglobin binding with
haptoglobin. Unequivocal demonstration that the
beta-chains of human haemoglobin bind to hapto-
globin. Biochem J. 1980;185:285-287.
35. Lustbader JW, Arcoleo JP, Birken S, Greer J. He-
moglobin-binding site on haptoglobin probed by
selective proteolysis. J Biol Chem. 1983;258:
1227-1234.
36. Yoshioka N, Atassi MZ. Haemoglobin binding with
haptoglobin. Localization of the haptoglobin-bind-
ing sites on the beta-chain of human haemoglo-
bin by synthetic overlapping peptides encom-
passing the entire chain. Biochem J. 1986;234:
453-456.
37. Kazim AL, Atassi MZ. Haemoglobin binding with
haptoglobin. Localization of the haptoglobin-bind-
ing site on the alpha-chain of human haemoglo-
bin. Biochem J. 1981;197:507-510.
38. McCormick DJ, Atassi MZ. Hemoglobin binding
with haptoglobin: delineation of the haptoglobin
binding site on the alpha-chain of human hemo-
globin. J Protein Chem. 1990;9:735-742.
39. Pipirou Z, Bottrill AR, Svistunenko DA, et al. The
reactivity of heme in biological systems: autocata-
lytic formation of both tyrosine-heme and trypto-
phan-heme covalent links in a single protein ar-
chitecture. Biochemistry. 2007;46:13269-13278.
40. Svistunenko DA, Reeder BJ, Wankasi MM, et al.
Reaction of Aplysia limacina metmyoglobin with
hydrogen peroxide. Dalton Trans. 2007:840-850.
41. Svistunenko DA, Wilson MT, Cooper CE. Trypto-
phan or tyrosine? On the nature of the amino acid
radical formed following hydrogen peroxide treat-
ment of cytochrome c oxidase. Biochim Biophys
Acta. 2004;1655:372-380.
42. Gunther MR, Tschirret-Guth RA, Witkowska HE,
et al. Site-specific spin trapping of tyrosine radi-
cals in the oxidation of metmyoglobin by hydro-
gen peroxide. Biochem J. 1998;330(pt 3):1293-
1299.
43. Lardinois OM, Ortiz de Montellano PR. Intra- and
intermolecular transfers of protein radicals in the
reactions of sperm whale myoglobin with hydro-
gen peroxide. J Biol Chem. 2003;278:36214-
36226.
44. Rogers MS, Ryan BB, Cashon RE, Alayash AI.
Effects of polymerization on the oxygen carrying
and redox properties of diaspirin cross-linked he-
moglobin. Biochim Biophys Acta. 1995;1248:135-
142.
45. Nagababu E, Rifkind JM. Reaction of hydrogen
peroxide with ferrylhemoglobin: superoxide pro-
duction and heme degradation. Biochemistry.
2000;39:12503-12511.
46. Alayash AI, Ryan BA, Eich RF, Olson JS, Cashon
RE. Reactions of sperm whale myoglobin with
hydrogen peroxide: effects of distal pocket muta-
tions on the formation and stability of the ferryl
intermediate. J Biol Chem. 1999;274:2029-2037.
47. Abraham NG, Drummond G. CD163-mediated
hemoglobin-heme uptake activates macrophage
HO-1, providing an antiinflammatory function.
Circ Res. 2006;99:911-914.
48. Schaer CA, Schoedon G, Imhof A, Kurrer MO,
Schaer DJ. Constitutive endocytosis of CD163
mediates hemoglobin-heme uptake and deter-
mines the noninflammatory and protective tran-
scriptional response of macrophages to hemoglo-
bin. Circ Res. 2006;99:943-950.
49. Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai
N. Haptoglobin phenotypes differ in their ability to
inhibit heme transfer from hemoglobin to LDL.
Biochemistry. 2004;43:3899-3906.
50. Buehler PW, D’Agnillo F, Hoffman V, Alayash AI.
Effects of endogenous ascorbate on oxidation,
oxygenation and toxicokinetics of cell-free modi-
fied hemoglobin after exchange transfusion in rat
and guinea pig. J Pharmacol Exp Ther. 2007;323:
49-60.
51. Kino K, Tsunoo H, Higa Y, Takami M, Hamaguchi
H, Nakajima H. Hemoglobin-haptoglobin receptor
in rat liver plasma membrane. J Biol Chem. 1980;
255:9616-9620.
52. Tolosano E, Hirsch E, Patrucco E, et al. Defective
recovery and severe renal damage after acute
hemolysis in hemopexin-deficient mice. Blood.
1999;94:3906-3914.
53. Buehler PW, Vallelian F, Mikolajczyk MG, et al.
Structural stabilization in tetrameric or polymeric
hemoglobin determines its interaction with en-
dogenous antioxidant scavenger pathways. Anti-
oxid Redox Signal. 2008;10:1449-1462.
54. Lim YK, Jenner A, Ali AB, et al. Haptoglobin re-
duces renal oxidative DNA and tissue damage
during phenylhydrazine-induced hemolysis. Kid-
ney Int. 2000;58:1033-1044.
55. Yang F, Haile DJ, Berger FG, Herbert DC, Van
Beveren E, Ghio AJ. Haptoglobin reduces lung
injury associated with exposure to blood. Am J
Physiol Lung Cell Mol Physiol. 2003;284:L402-
L409.
56. Maniecki MB, Hasle H, Friis-Hansen L, et al. Im-
paired CD163-mediated hemoglobin-scavenging
and severe toxic symptoms in patients treated
with gemtuzumab ozogamicin. Blood. 2008;112:
1510-1514.
57. Chiancone E, Antonini E, Brunori M, Alfsen A,
Lavialle F. Kinetics of the reaction between oxy-
gen and haemoglobin bound to haptoglobin. Bio-
chem J. 1973;133:205-207.
58. Azarov I, He X, Jeffers A, et al. Rate of nitric oxide
scavenging by hemoglobin bound to haptoglobin.
Nitric Oxide. 2008;18:296-302.
2586 BUEHLER et al BLOOD, 12 MARCH 2009  VOLUME 113, NUMBER 11
 For personal use only. at UNIVERSITAETSSPITAL on August 20, 2009. www.bloodjournal.orgFrom 
